|
The Addiction Psychiatry Fellowship curriculum will give you the
skills, clinical judgment and knowledge necessary to practice addiction
psychiatry to enable you to assume a leadership position in the
field.
Your training will give you clinical experience in diagnostic and
therapeutic addiction psychiatry with specific skill development
in:
- Ability to perform and record from the biopsychosocial
and functional perspectives an accurate and comprehensive psychiatric
evaluation of the patient with psychoactive substance related
disorders.
- Capacity to arrive at a differential diagnosis
of all substance related disorders, including abuse, dependence,
intoxication, withdrawal, substance-induced mood, anxiety, delirium
and psychotic disorders, as well as all other concomitant Axis
I and II psychiatric disorders.
- Skills to create comprehensive treatment plans
from a biopsychosocial and multidisciplinary perspective for patients
with psychoactive substance related disorders.
- Ability to assess and manage patients with psychoactive
substance related disorders in the inpatient, intensive outpatient
and ambulatory care settings.
- Expertise in utilizing multidisciplinary team
members in the development of and execution of the comprehensive
treatment plan.
- Experience in the use of a variety of psychotherapeutic
techniques for treatment of psychoactive substance dependence,
including motivational interviewing, psychoeducation, relapse
prevention, and supportive, cognitive-behavioral, psychodynamic,
couples, family, and group therapies.
- Adept in intermediate term, individual psychiatric
treatment of psychoactive substance dependent outpatients.
- Competence in psychopharmacologic treatment
of substance use disorders (including opioid substitution therapy,
opioid antagonist therapy, nicotine replacement therapy, relapse
prevention, and agents used for medically supervised withdrawal),
as well as in psychopharmacologic treatment of co-morbid psychiatric
disorders.
Rotations
While you are a trainee in the Addiction Psychiatry Fellowship,
you will spend:
- Three to four months in the residential addiction
treatment program
- Three or four months in the outpatient addiction
program
- Two to three months in research
- One month in opioid maintenance
- Additional elective time in pain management,
consultation/liaison psychiatry, adolescent addiction consultations
and a dual disorders continuity care clinic
Didactic Training
You will participate in and learn to coordinate regular
weekly psychiatry conferences. In addition, you will have close
contact with the clinical psychiatry services. There will also be
opportunities to observe addiction studies with patients and attend
various psychiatry and psychology conferences.
Research Training
Mayo Clinic has established a landmark research program
in the genomics of addiction with the long-term goal of predicting
and preventing alcoholism and other chemical dependencies.
The first step in the research is to identify human genes that
contribute to the individual's vulnerability to alcoholism. The
next step will be to develop ways to use the genetic information
to protect the patient from becoming addicted. Ultimately, people
who are at increased risk of becoming addicted could receive personalized
therapy that could change their lives.
To meet its ongoing commitment to provide cutting-edge patient
care, the Department of Psychiatry and Psychology at Mayo Clinic
is involved with multiple research projects including:
- Psychogenomics
- Electroconvulsive therapy
- Cognitive disorders
- Transcranial magnetic stimulation
- Other neuropsychiatric treatment
- Sleep disorder
- Nicotine dependence
- Eating disorder
- Obsessive-compulsive disorder
Also see:
Additional Training
Educational opportunities are available in a variety of
clinical settings including clinic-and hospital–based outpatient
treatment programs, as well as in the consultation-liaison setting.
An additional opportunity is available to learn to treat nicotine
dependency in Mayo Clinic's Nicotine Dependency Center . Fellows
have an opportunity to participate in ongoing research through the
Samuel Johnson Genomics of Addiction Program at Mayo Clinic.
|